Clinical trials
Active, not recruiting Phase 2 Carcinoma, Transitional Cell trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2016 | 1 |
| 2017 | 4 |
| 2018 | 1 |
| 2019 | 2 |
| 2021 | 4 |
| 2022 | 4 |
| 2023 | 3 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 21 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 5 |
| Fox Chase Cancer Center | 2 |
| Memorial Sloan Kettering Cancer Center | 2 |
| National Cancer Institute (NCI) | 2 |
| AbbVie | 1 |
| EMD Serono Research & Development Institute, Inc. | 1 |
| Emory University | 1 |
| ImmunityBio, Inc. | 1 |
| Matthew Galsky | 1 |
| Rahul Aggarwal | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Transitional Cell | 21 |
| Urinary Bladder Neoplasms | 9 |
| Carcinoma, Renal Cell | 3 |
| Ureteral Neoplasms | 3 |
| Urethral Neoplasms | 3 |
| Carcinoma, Hepatocellular | 2 |
| Cholangiocarcinoma | 2 |
| Melanoma | 2 |
| Neoplasm Metastasis | 2 |
| Small Cell Lung Carcinoma | 2 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.